MedImmune announced that the FDA has approved the use of its FluMist in children 2-5 years old, an indication that significantly expands the market for the nasal vaccine.
Pfizer is set to roll out a DTC campaign for smoking-cessation aid Chantix next week, an executive said today.
Company news
September 18, 2007
4:00 am
Drug developer Depomed said it would cut about 25% of its workforce after its lead drug candidate, Gabapentin GR, failed in a late-stage clinical trial.
People news
September 18, 2007
4:00 am
Acceleron Pharma, a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, announced that John Knopf, Ph.D., has been named as CEO.
Product news
September 18, 2007
4:00 am
The FDA approved Eli Lillys osteoporosis drug Evista to reduce breast cancer risk in some postmenopausal women.
New York State Attorney General Andrew Cuomo and New York City Mayor Michael Bloomberg have filed a joint lawsuit against Merck, alleging the drugmaker misrepresented the cardiovascular risks associated with its Vioxx painkiller.
AstraZeneca disclaims exec’s remarks on outsourcing
AstraZeneca today issued a statement disclaiming remarks made by its global operations chief in a UK newspaper implying plans to outsource all of its supply and manufacturing activities.
Generic Zocor chips away at Lipitor’s statin market dominance
Pfizer chairman Jeff Kindler said during last weeks Bear Stearns Healthcare Conference that the company expects Lipitor sales to be flat or down up to 5% on last years numbers due to competition from generic Zocor (simvastatin).
AstraZeneca to outsource all manufacturing within next decade: report